AVITA Medical, Inc. (RCEL) Shares Outstanding (2018 - 2026)

AVITA Medical (RCEL) has reported Shares Outstanding (Entity) for 9 consecutive years, with $30.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 16.21% year-over-year to $30.9 million; the trailing twelve-month figure through Jun 2026 stood at $30.9 million (up 16.21% YoY), and the FY2025 full-year result was $30.6 million, up 16.0% from the prior year.
• Shares Outstanding (Entity) advanced to $30.9 million in Q2 2026 per RCEL's latest filing, from $30.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $30.9 million in Q2 2026 and bottomed at $25.0 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $26.6 million across 5 years, with a median of $25.8 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 0.42% in 2022, then advanced 16.31% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $25.2 million in 2022, then rose by 1.88% to $25.7 million in 2023, then increased by 2.62% to $26.4 million in 2024, then gained by 16.0% to $30.6 million in 2025, then rose by 1.16% to $30.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $30.9 million, $30.6 million, and $30.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.